BIOMAT Database Logo BIOMAT Database Logo

Maximal discrimination of renovascular from essential hypertension by the saralasin test. 1978

M H Maxwell, and P Varady, and E T Zawada, and J F Burkhalter, and U Waks, and L Marks

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D006978 Hypertension, Renovascular Hypertension due to RENAL ARTERY OBSTRUCTION or compression. Hypertension, Goldblatt,Goldblatt Syndrome,Goldblatt Hypertension,Renovascular Hypertension,Syndrome, Goldblatt
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D003971 Diastole Post-systolic relaxation of the HEART, especially the HEART VENTRICLES. Diastoles
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D012504 Saralasin An octapeptide analog of angiotensin II (bovine) with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II that is used in the diagnosis of HYPERTENSION. 1-Sar-8-Ala Angiotensin II,1-Sarcosine-8-Alanine Angiotensin II,(Sar(1),Ala(8))ANGII,(Sar1,Val5,Ala8)Angiotensin II,Angiotensin II, Sar(1)-Ala(8)-,Angiotensin II, Sarcosyl(1)-Alanine(8)-,Sar-Arg-Val-Tyr-Val-His-Pro-Ala,Saralasin Acetate,Saralasin Acetate, Anhydrous,Saralasin Acetate, Hydrated,1 Sar 8 Ala Angiotensin II,1 Sarcosine 8 Alanine Angiotensin II,Angiotensin II, 1-Sar-8-Ala,Angiotensin II, 1-Sarcosine-8-Alanine,Anhydrous Saralasin Acetate,Hydrated Saralasin Acetate

Related Publications

M H Maxwell, and P Varady, and E T Zawada, and J F Burkhalter, and U Waks, and L Marks
Saralasin infusion in renovascular and essential hypertension.
January 1980, The Netherlands journal of medicine,
M H Maxwell, and P Varady, and E T Zawada, and J F Burkhalter, and U Waks, and L Marks
[Saralasin for renovascular or essential hypertension (author's transl)].
November 1978, Deutsche medizinische Wochenschrift (1946),
M H Maxwell, and P Varady, and E T Zawada, and J F Burkhalter, and U Waks, and L Marks
Detection of renovascular hypertension: saralasin test versus renin determinations.
October 1976, The Journal of urology,
M H Maxwell, and P Varady, and E T Zawada, and J F Burkhalter, and U Waks, and L Marks
[The Saralasin test in the diagnosis of renovascular hypertension. Personal experience].
January 1979, Minerva nefrologica,
M H Maxwell, and P Varady, and E T Zawada, and J F Burkhalter, and U Waks, and L Marks
Saralasin for diagnosis of renovascular hypertension.
January 1982, The Medical letter on drugs and therapeutics,
M H Maxwell, and P Varady, and E T Zawada, and J F Burkhalter, and U Waks, and L Marks
Urology: value of saralasin test in detection of human renovascular hypertension.
January 1977, The Western journal of medicine,
M H Maxwell, and P Varady, and E T Zawada, and J F Burkhalter, and U Waks, and L Marks
Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
August 1977, Annals of internal medicine,
M H Maxwell, and P Varady, and E T Zawada, and J F Burkhalter, and U Waks, and L Marks
Saralasin infusion in the recognition of renovascular hypertension.
July 1977, Annals of internal medicine,
M H Maxwell, and P Varady, and E T Zawada, and J F Burkhalter, and U Waks, and L Marks
Negative saralasin response in correctable renovascular hypertension.
September 1978, The Journal of pediatrics,
M H Maxwell, and P Varady, and E T Zawada, and J F Burkhalter, and U Waks, and L Marks
False-negative saralasin responses in renovascular hypertension.
April 1979, British journal of urology,
Copied contents to your clipboard!